Invivo Therapeutics Holdings (NVIV) has released an update to notify the public and investors about listing compliance status.
InVivo Therapeutics Holdings Corp. and its subsidiary have filed for Chapter 11 bankruptcy, leading to Nasdaq’s decision to delist the company’s common stock. The delisting will not impact the company’s bankruptcy proceedings, and trading of its stock on Nasdaq will be suspended starting February 13, 2024.
For further insights into NVIV stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
